+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Sickle Cell Disease Clinical Trial Pipeline Highlights - 2019

  • ID: 4773933
  • Report
  • March 2019
  • Region: Global
  • Fore Pharma
1 of 2

This report, Sickle Cell Disease Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Sickle Cell Disease market. It covers emerging therapies for Sickle Cell Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives in tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Sickle Cell Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Sickle Cell Disease pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Sickle Cell Disease pipeline products by the company.

Short-term Launch Highlights:

Find out which Sickle Cell Disease pipeline products will be launched in the US and Ex-US to 2024.

Summary:

  • Sickle Cell Disease phase 3 clinical trial pipeline products
  • Sickle Cell Disease phase 2 clinical trial pipeline products
  • Sickle Cell Disease phase 1 clinical trial pipeline products
  • Sickle Cell Disease preclinical research pipeline products
  • Sickle Cell Disease discovery stage pipeline products
  • Sickle Cell Disease pipeline products short-term launch highlights

Note: Please allow up to 48 hours for delivery after order is placed.
Please Note: This report will be delivered within 2 business days of ordering.
Note: Product cover images may vary from those shown
2 of 2
1. Sickle Cell Disease Pipeline by Stages

2. Sickle Cell Disease Phase 3 Clinical Trial Insights

3. Sickle Cell Disease Phase 2 Clinical Trial Insights

4. Sickle Cell Disease Phase 1 Clinical Trial Insights

5. Sickle Cell Disease Preclinical Research Insights

6. Sickle Cell Disease Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables:
Table 1: Sickle Cell Disease Phase 3 Clinical Trials, 2019
Table 2: Sickle Cell Disease Phase 2 Clinical Trials, 2019
Table 3: Sickle Cell Disease Phase 1 Clinical Trials, 2019
Table 4: Sickle Cell Disease Preclinical Research, 2019
Table 5: Sickle Cell Disease Discovery Stage, 2019

List of Figures:
Figure 1:: Sickle Cell Disease Pipeline Molecules by Clinical Trials Stage, 2019
Figure 2: Sickle Cell Disease Phase 3 Clinical Trial Highlights, 2019
Figure 3: Sickle Cell Disease Phase 2 Clinical Trial Highlights, 2019
Figure 4: Sickle Cell Disease Phase 1 Clinical Trial Highlights, 2019
Figure 5: Sickle Cell Disease Preclinical Research Highlights, 2019
Figure 6: Sickle Cell Disease Discovery Stage Highlights, 2019
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll